NCT03913286Completed
Neuromotor Prosthetic to Treat Stroke-Related Paresis
Source: ClinicalTrials.gov · Last updated 16 Apr 2025
Brief summary (registry, in English)
The purpose of the research is to develop a new medical device prototype to restore functional movement of an arm made weak due to a chronic stroke
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1 (actual)
- First submitted
- 7 Mar 2019
- Start date
- 1 May 2019
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Thomas Jefferson University
- Diseases
- Stroke
- NCT number
- NCT03913286
What you commit to
- Study type: Interventional
- Participants enrolled: 1
- From 1 May 2019 to the primary completion date, 1 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Chronic oral or intravenous steroids or immunosuppressive therapy
- Medical contraindications for general anesthesia, craniotomy, or surgery.
- Diagnosis of acute myocardial infarction or cardiac arrest within previous 6 months.
- Co-morbid conditions that would interfere with study activities or response to treatment, which may include:
- Life expectancy \< 3 years
- Severe chronic pulmonary disease
- Seizure within three months prior to enrollment
- History of uncontrolled seizures
- Local, systemic acute or chronic infectious illness
- Life threatening cardiac arrhythmias
- Severe collagen vascular disorder
- Participation in another investigational device or medication trial
- Participating in any experimental rehabilitation or drug studies
- Received phenol injections to any portion of the paretic upper extremity within the past 12 months
Other illness
- No history of poorly controlled autonomic dysreflexia.
- Visual impairment such that extended viewing of a computer monitor would be challenging even with ordinary corrective lenses
- Orthopedic conditions of either arm that would affect performance on study
- Untreated psychiatric disturbances that would affect motivation and trial participation
- Dementia
- Other implantable devices such as heart/brain pacemakers
- Kidney failure or other major organ system failures History of a neurological ablation procedure.
- History of HIV infection or ongoing chronic infection (such as tuberculosis).
- Other conditions or circumstances that, in the opinion of the investigators, would preclude safe and/or effective participation, including severe skin conditions, and/or other sequelae that may be contraindicated for arm orthosis use as well as personal circumstance
Lab values
- No medical condition requiring active anti-coagulation with a medication such as heparin, warfarin or rivaroxaban (note that anti-platelet agents such as aspirin or clopidogrel are acceptable)
Other
- No active wound healing or skin breakdown issues.
- A score of 23 or lower on Folstein's Mini-Mental Status Examination
- Participants who rely on ventilators
- Labeled contraindication for MRI.
- Pregnant or of child-bearing potential and are not taking acceptable methods of contraception.
- Excessive pain in the paretic upper extremity (\> 5 on a 10-point visual analog scale)
- Excessive spasticity at the paretic elbow, wrist, or digits as defined as a score of \> 2 on the Modified Ashworth Spasticity Scale
- Moderate to severe apraxia (\< 2.5 on the Alexander scale)
Who the study is looking for
- Must be 18 years or older.
- Clinical diagnosis of stroke (hemorrhagic or ischemic, cortical or subcortical), confirmed by brain computer tomography or magnetic resonance imaging, that occurred six or more months prior to enrollment
- Must have arm weakness due to stroke.
- Participant is willing to comply with all follow-up evaluations at the specified times.
- Participant is able to provide informed consent prior to enrollment in the study.
- The participant is fluent in English.
- \> 24 on the Mini Mental Status Examination
- Medically stable.
- Passive flexion of shoulder in weakened upper extremity with range of \> 30 degrees or more
- Passive abduction of shoulder in weakened upper extremity with range of \> 20 degrees or more
- Participant must have a caregiver willing to participate in the study who will help provide care for the surgical site.
- Must be willing to live at hospital or at nearby hotel for 90-day duration when implantable components were present.
- Plateaued post-stroke recovery with complete or incomplete hemiplegia due to stroke in one upper limb, as measured on two serial occasions (at least one month apart) without improvement, by the following standardized functional assessments of the weaker upper extremity, at their worst:
- Manual Muscle Testing scores of 0/5 (no movement) or 1/5 (palpable contraction in muscle, without movement) in the biceps (elbow flexion), triceps (elbow extension), wrist flexors, wrist extensors or intrinsic hand muscles
- Mild to plegia according to Medical Research Council Scale for Muscle Strength
- Fugl-Meyer Motor Impairment Score of 38 or lower
- Action Research Arm Test (ARAT) score of 35 or lower
- Motricity Index score of 55 or lower
- No joint contracture or severe spasticity in affected upper limb precluding the operation of the MyoPro orthotic device.
- Sufficient sitting balance to participate with robotic brace activities.
- No condition (e.g., severe arthritis, central pain) that would interfere with administration of motor function tests, ability to understand verbal commands and cooperate with test procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thomas Jefferson University Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.